vs

Side-by-side financial comparison of NPK International Inc. (NPKI) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.

NPK International Inc. is the larger business by last-quarter revenue ($75.2M vs $39.6M, roughly 1.9× SBC Medical Group Holdings Inc). On growth, NPK International Inc. posted the faster year-over-year revenue change (30.7% vs -10.9%). SBC Medical Group Holdings Inc produced more free cash flow last quarter ($51.2M vs $5.8M). Over the past eight quarters, NPK International Inc.'s revenue compounded faster (23.9% CAGR vs -15.0%).

SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.

NPKI vs SBC — Head-to-Head

Bigger by revenue
NPKI
NPKI
1.9× larger
NPKI
$75.2M
$39.6M
SBC
Growing faster (revenue YoY)
NPKI
NPKI
+41.6% gap
NPKI
30.7%
-10.9%
SBC
More free cash flow
SBC
SBC
$45.4M more FCF
SBC
$51.2M
$5.8M
NPKI
Faster 2-yr revenue CAGR
NPKI
NPKI
Annualised
NPKI
23.9%
-15.0%
SBC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NPKI
NPKI
SBC
SBC
Revenue
$75.2M
$39.6M
Net Profit
$14.2M
Gross Margin
37.7%
73.1%
Operating Margin
16.7%
32.5%
Net Margin
35.9%
Revenue YoY
30.7%
-10.9%
Net Profit YoY
117.2%
EPS (diluted)
$0.17
$0.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NPKI
NPKI
SBC
SBC
Q4 25
$75.2M
$39.6M
Q3 25
$68.8M
$43.4M
Q2 25
$68.2M
$43.4M
Q1 25
$64.8M
$47.3M
Q4 24
$57.5M
$44.4M
Q3 24
$44.2M
$53.1M
Q2 24
$66.8M
$53.1M
Q1 24
$49.0M
$54.8M
Net Profit
NPKI
NPKI
SBC
SBC
Q4 25
$14.2M
Q3 25
$5.7M
$12.8M
Q2 25
$8.7M
$2.5M
Q1 25
$10.0M
$21.5M
Q4 24
$6.5M
Q3 24
$-174.3M
$2.8M
Q2 24
$8.0M
$18.5M
Q1 24
$7.3M
$18.8M
Gross Margin
NPKI
NPKI
SBC
SBC
Q4 25
37.7%
73.1%
Q3 25
31.9%
70.6%
Q2 25
36.9%
69.2%
Q1 25
39.0%
79.7%
Q4 24
39.2%
76.3%
Q3 24
27.5%
81.5%
Q2 24
37.2%
74.2%
Q1 24
36.0%
72.1%
Operating Margin
NPKI
NPKI
SBC
SBC
Q4 25
16.7%
32.5%
Q3 25
13.2%
36.6%
Q2 25
17.0%
33.6%
Q1 25
20.9%
51.1%
Q4 24
20.2%
10.6%
Q3 24
2.8%
26.1%
Q2 24
18.7%
51.4%
Q1 24
14.2%
44.6%
Net Margin
NPKI
NPKI
SBC
SBC
Q4 25
35.9%
Q3 25
8.2%
29.6%
Q2 25
12.7%
5.7%
Q1 25
15.4%
45.4%
Q4 24
14.7%
Q3 24
-394.3%
5.3%
Q2 24
12.0%
34.8%
Q1 24
14.9%
34.2%
EPS (diluted)
NPKI
NPKI
SBC
SBC
Q4 25
$0.17
$0.15
Q3 25
$0.07
$0.12
Q2 25
$0.10
$0.02
Q1 25
$0.11
$0.21
Q4 24
$0.10
$0.05
Q3 24
$-1.99
$0.03
Q2 24
$0.09
$0.20
Q1 24
$0.08
$0.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NPKI
NPKI
SBC
SBC
Cash + ST InvestmentsLiquidity on hand
$5.1M
$164.1M
Total DebtLower is stronger
$16.9M
$42.8M
Stockholders' EquityBook value
$351.2M
$248.3M
Total Assets
$441.8M
$380.4M
Debt / EquityLower = less leverage
0.05×
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NPKI
NPKI
SBC
SBC
Q4 25
$5.1M
$164.1M
Q3 25
$35.6M
$127.4M
Q2 25
$26.0M
$152.7M
Q1 25
$20.8M
$132.1M
Q4 24
$17.8M
$125.0M
Q3 24
$42.9M
$137.4M
Q2 24
$35.1M
Q1 24
$37.7M
Total Debt
NPKI
NPKI
SBC
SBC
Q4 25
$16.9M
$42.8M
Q3 25
$9.5M
$21.1M
Q2 25
$9.3M
$7.1M
Q1 25
$8.1M
$6.9M
Q4 24
$7.7M
$6.6M
Q3 24
$14.0M
$823.2K
Q2 24
$58.0M
Q1 24
$77.4M
Stockholders' Equity
NPKI
NPKI
SBC
SBC
Q4 25
$351.2M
$248.3M
Q3 25
$333.9M
$248.0M
Q2 25
$328.8M
$244.6M
Q1 25
$326.9M
$226.4M
Q4 24
$326.5M
$195.1M
Q3 24
$316.5M
$205.0M
Q2 24
$426.6M
$8.8M
Q1 24
$421.6M
$9.0M
Total Assets
NPKI
NPKI
SBC
SBC
Q4 25
$441.8M
$380.4M
Q3 25
$404.5M
$321.4M
Q2 25
$393.7M
$315.3M
Q1 25
$390.0M
$284.6M
Q4 24
$393.7M
$266.1M
Q3 24
$389.6M
$296.5M
Q2 24
$624.8M
$19.5M
Q1 24
$640.8M
$19.8M
Debt / Equity
NPKI
NPKI
SBC
SBC
Q4 25
0.05×
0.17×
Q3 25
0.03×
0.09×
Q2 25
0.03×
0.03×
Q1 25
0.02×
0.03×
Q4 24
0.02×
0.03×
Q3 24
0.04×
0.00×
Q2 24
0.14×
Q1 24
0.18×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NPKI
NPKI
SBC
SBC
Operating Cash FlowLast quarter
$18.0M
$52.0M
Free Cash FlowOCF − Capex
$5.8M
$51.2M
FCF MarginFCF / Revenue
7.6%
129.3%
Capex IntensityCapex / Revenue
16.3%
2.0%
Cash ConversionOCF / Net Profit
3.66×
TTM Free Cash FlowTrailing 4 quarters
$26.3M
$23.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NPKI
NPKI
SBC
SBC
Q4 25
$18.0M
$52.0M
Q3 25
$24.7M
$-20.9M
Q2 25
$21.4M
$-8.3M
Q1 25
$8.8M
$1.9M
Q4 24
$-4.1M
$-7.3M
Q3 24
$2.8M
$5.0M
Q2 24
$27.6M
$19.2M
Q1 24
$11.9M
$3.7M
Free Cash Flow
NPKI
NPKI
SBC
SBC
Q4 25
$5.8M
$51.2M
Q3 25
$12.0M
$-20.9M
Q2 25
$9.7M
$-8.6M
Q1 25
$-1.2M
$1.7M
Q4 24
$-17.7M
$-7.9M
Q3 24
$-6.7M
$4.6M
Q2 24
$21.0M
$18.3M
Q1 24
$-1.9M
$3.0M
FCF Margin
NPKI
NPKI
SBC
SBC
Q4 25
7.6%
129.3%
Q3 25
17.4%
-48.3%
Q2 25
14.3%
-19.9%
Q1 25
-1.8%
3.5%
Q4 24
-30.8%
-17.8%
Q3 24
-15.2%
8.7%
Q2 24
31.4%
34.5%
Q1 24
-3.9%
5.4%
Capex Intensity
NPKI
NPKI
SBC
SBC
Q4 25
16.3%
2.0%
Q3 25
18.5%
0.1%
Q2 25
17.1%
0.7%
Q1 25
15.5%
0.5%
Q4 24
23.6%
1.3%
Q3 24
21.4%
0.8%
Q2 24
9.9%
1.6%
Q1 24
28.3%
1.3%
Cash Conversion
NPKI
NPKI
SBC
SBC
Q4 25
3.66×
Q3 25
4.37×
-1.63×
Q2 25
2.47×
-3.39×
Q1 25
0.88×
0.09×
Q4 24
-1.12×
Q3 24
1.77×
Q2 24
3.43×
1.04×
Q1 24
1.64×
0.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NPKI
NPKI

Rental Revenue$34.8M46%
Products$25.5M34%
Services$14.9M20%

SBC
SBC

Franchising$10.3M26%
Medical Corporation Shobikai$8.1M21%
Medical Corporation Nasukai$7.2M18%
Management Services$6.3M16%
Rental Services$4.3M11%
Medical Corporation Association Furinkai$3.0M8%
Japan Medical And Beauty Inc$656.5K2%

Related Comparisons